Glass House Brands (GLAS) Treasury Shares (2022 - 2024)
Glass House Brands' (GLAS) quarterly Treasury Shares came in at $3.3 million in Q4 2024, up 6572.71% on a QoQ basis from $49969.0 in Q4 2022.
Glass House Brands (GLAS) Treasury Shares (2022 - 2024) Analysis & Trends
Glass House Brands (GLAS) has 2 years of Treasury Shares data on file, last reported at $3.3 million in Q4 2024.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $3.3 million in Q4 2024; TTM through Dec 2024 was $3.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.3 million, up 59.76% from the prior year.
- Treasury Shares for Q4 2024 stood at $3.3 million, up from $49969.0 in the prior quarter.
- Over the last five years, Treasury Shares for GLAS reached as high as $3.3 million in Q4 2024 and fell as low as $49969.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 81.54 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 5.44 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.33 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Dec 31, 2022 | 49,969.00 |
| Dec 31, 2022 | 49,969.00 |